Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL1R1 | P14778 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17667121 | 0.98 | IL1R1 (0.31) | IL1R1L3MBTL1MEN1ALDH1A1MAPT | |
| SCHEMBL17667127 | 0.97 | IL1R1 (0.32) | IL1R1L3MBTL1MEN1ALDH1A1MAPT | |
| SCHEMBL17667119 | 0.95 | PDK2 (0.30) | IL1R1L3MBTL1KDM4EATM | |
| SCHEMBL17667130 | 0.95 | PDK2 (0.31) | IL1R1 | |
| SCHEMBL17667140 | 0.95 | — | — | |
| SCHEMBL17667136 | 0.94 | PDK2 (0.30) | — | |
| SCHEMBL17667141 | 0.93 | IL1R1 (0.37) | IL1R1L3MBTL1MEN1ALDH1A1MAPT | |
| SCHEMBL17677062 | 0.91 | PGR (0.30) | — | |
| SCHEMBL17677053 | 0.90 | PDK2 (0.31) | — | |
| SCHEMBL15861014 | 0.90 | KDM4E (0.33) | IL1R1L3MBTL1KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3006426-B1 | INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2019-01-09 | — | — | EP | disclosed |
| US-9985216-B2 | Indenoindole derivative and organic electroluminescent element | HODOGAYA CHEMICAL CO., LTD. (JP) | 2018-05-29 | — | — | US | disclosed |
| US-20160126468-A1 | INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO., LTD. (JP) | 2016-05-05 | — | — | US | disclosed |
| EP-3006426-A1 | INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2016-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126468-A1 | INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | IDO2, SLCO2B1, IDO1 | IL1R1 2572/4885L3MBTL1 2737/4885MEN1 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.